Literature DB >> 23997366

Effect of psychostimulants on impulsivity and risk taking in narcolepsy with cataplexy.

Sophie Bayard1, Muriel Croisier Langenier, Yves Dauvilliers.   

Abstract

OBJECTIVE: To investigate the effect of psychostimulants on impulsivity, depressive symptoms, addiction, pathological gambling, and risk-taking using objective sensitivity tests in narcolepsy with cataplexy (NC). Drug-free patients with NC present alterations in reward processing, but changes with psychostimulants remain unknown.
DESIGN: Prospective case-control study.
SETTING: Academic sleep disorders center. PARTICIPANTS: There were 120 participants: 41 drug-free patients with NC, 37 patients with NC taking psychostimulants, and 42 matched healthy controls.
INTERVENTIONS: All participants underwent a semistructured clinical interview for impulse control and addictive behaviors and completed questionnaires for depression and impulsivity. Risk taking was analyzed through performance on a decision-making task under ambiguity (Iowa Gambling Task [IGT]) and under risk (Game of Dice Task [GDT]). All patients with NC underwent 1 night of polysomnography followed by a multiple sleep latency test for drug-free patients and a maintenance wakefulness test for treated patients.
RESULTS: Depressive symptoms were higher in drug-free patients than in treated patients and controls, with no difference between controls and treated patients. No between-group differences were found for impulsivity, substance addiction, or pathological gambling. Drug-free and treated patients showed selective reduced performance on the IGT and normal performance on the GDT compared with controls, with no differences between patients taking medication and those who did not. No clinical or polysomnographic characteristics or medication type was associated with IGT scores.
CONCLUSIONS: Our results demonstrated that, whether taking psychostimulants or not, patients with narcolepsy with cataplexy preferred risky choices on a decision-making task under ambiguity. However, the lack of association with impulsivity, pathological gambling, or substance addiction remains of major clinical interest in narcolepsy with cataplexy.

Entities:  

Keywords:  Addiction; Game of Dice Task; Iowa Gambling Task; decision making; hypocretin; impulsivity; narcolepsy; pathological gambling; stimulant

Mesh:

Substances:

Year:  2013        PMID: 23997366      PMCID: PMC3738042          DOI: 10.5665/sleep.2958

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  28 in total

Review 1.  Emotion, decision making and the orbitofrontal cortex.

Authors:  A Bechara; H Damasio; A R Damasio
Journal:  Cereb Cortex       Date:  2000-03       Impact factor: 5.357

2.  Decision-making deficits of korsakoff patients in a new gambling task with explicit rules: associations with executive functions.

Authors:  Matthias Brand; Esther Fujiwara; Sabine Borsutzky; Elke Kalbe; Josef Kessler; Hans J Markowitsch
Journal:  Neuropsychology       Date:  2005-05       Impact factor: 3.295

Review 3.  The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness.

Authors:  Takeshi Sakurai
Journal:  Nat Rev Neurosci       Date:  2007-02-14       Impact factor: 34.870

4.  A further evaluation of decision-making under risk and under ambiguity in schizophrenia.

Authors:  Guillaume Fond; Sophie Bayard; Delphine Capdevielle; Jonathan Del-Monte; Nawale Mimoun; Alexandra Macgregor; Jean-Philippe Boulenger; Marie-Christine Gely-Nargeot; Stéphane Raffard
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-05-26       Impact factor: 5.270

5.  [The estimation of premorbid intelligence levels in French speakers].

Authors:  A Mackinnon; R Mulligan
Journal:  Encephale       Date:  2005 Jan-Feb       Impact factor: 1.291

6.  Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil.

Authors:  J P Wisor; K S Eriksson
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

Review 7.  Narcolepsy with cataplexy.

Authors:  Yves Dauvilliers; Isabelle Arnulf; Emmanuel Mignot
Journal:  Lancet       Date:  2007-02-10       Impact factor: 79.321

8.  Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test.

Authors:  Michael R Littner; Clete Kushida; Merrill Wise; David G Davila; Timothy Morgenthaler; Teofilo Lee-Chiong; Max Hirshkowitz; L Loube Daniel; Dennis Bailey; Richard B Berry; Sheldon Kapen; Milton Kramer
Journal:  Sleep       Date:  2005-01       Impact factor: 5.849

9.  Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats.

Authors:  Eric Murillo-Rodríguez; Reyes Haro; Marcela Palomero-Rivero; Diana Millán-Aldaco; René Drucker-Colín
Journal:  Behav Brain Res       Date:  2006-11-13       Impact factor: 3.332

Review 10.  The somatic marker hypothesis: a critical evaluation.

Authors:  Barnaby D Dunn; Tim Dalgleish; Andrew D Lawrence
Journal:  Neurosci Biobehav Rev       Date:  2005-09-27       Impact factor: 8.989

View more
  4 in total

1.  Update on therapy for narcolepsy.

Authors:  Michael J Thorpy
Journal:  Curr Treat Options Neurol       Date:  2015-05       Impact factor: 3.598

Review 2.  Treatment Options for Narcolepsy.

Authors:  Lucie Barateau; Régis Lopez; Yves Dauvilliers
Journal:  CNS Drugs       Date:  2016-05       Impact factor: 5.749

3.  Smoking, Alcohol, Drug Use, Abuse and Dependence in Narcolepsy and Idiopathic Hypersomnia: A Case-Control Study.

Authors:  Lucie Barateau; Isabelle Jaussent; Régis Lopez; Benjamin Boutrel; Smaranda Leu-Semenescu; Isabelle Arnulf; Yves Dauvilliers
Journal:  Sleep       Date:  2016-03-01       Impact factor: 5.849

4.  Reward-based behaviors and emotional processing in human with narcolepsy-cataplexy.

Authors:  Sophie Bayard; Yves A Dauvilliers
Journal:  Front Behav Neurosci       Date:  2013-05-23       Impact factor: 3.558

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.